 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| YYC405 / Yooyoung Pharma
Enrollment closed: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients (clinicaltrials.gov) - Jun 1, 2022
P3, N=256, Active, not recruiting, Sponsor: Yooyoung Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting
- |||||||||| YYC405 / Yooyoung Pharma
New P3 trial: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients (clinicaltrials.gov) - Feb 7, 2022
P3, N=256, Recruiting, Sponsor: Yooyoung Pharmaceutical Co., Ltd.